Novel Non-stimulant ADHD Treatments: A Review for Pharmacists | PTCE Pharmacy Connect
Educational Objectives
Describe the impact of ADHD and new non-stimulant class of ADHD treatments
Highlight the role of the pharmacist in patient counseling, monitoring and medication management in ADHD
Faculty:
Sandy Mullen, PharmD, BCPP
Clinical Pharmacy Specialist - Child and Adolescent Psychiatry
Department of Pharmacy
Virginia Commonwealth University (VCU) Health
Richmond, VA
Sandy Mullen, PharmD, BCPP, has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-22-127-H01-P. The activity is available for CE credit through March 30, 2023.
This activity is supported by an educational grant from Supernus.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Describe the impact of ADHD and new non-stimulant class of ADHD treatments
Highlight the role of the pharmacist in patient counseling, monitoring and medication management in ADHD
Faculty:
Sandy Mullen, PharmD, BCPP
Clinical Pharmacy Specialist - Child and Adolescent Psychiatry
Department of Pharmacy
Virginia Commonwealth University (VCU) Health
Richmond, VA
Sandy Mullen, PharmD, BCPP, has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-22-127-H01-P. The activity is available for CE credit through March 30, 2023.
This activity is supported by an educational grant from Supernus.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Activity